1921
Volume 101, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide, including in regions where helminth infections such as the fish-borne liver fluke () also occur. We investigated the effects of a high-fat and high-fructose (HFF) diet on the development and progression of NAFLD in experimental opisthorchiasis. Two groups of hamsters were infected with for 4 months before the experiment to induce chronic inflammation. One of these groups (HFF) was fed with a HFF diet for up to further 4 months. One uninfected group of hamsters served as the normal control group, and another received the HFF diet (HFF group) for up to 4 months. Histopathology, biochemical parameters, and ultrastructural features of liver were investigated. In a short-term treatment, the HFF group showed significantly better homeostatic model assessment for insulin resistance level and lower liver lipid than did the HFF group. By contrast, histopathological characteristics of severe NAFLD were prominent in the HFF group after 4 months on the HFF diet, findings which were supported by confirmatory ultrastructural changes. In conclusion, opisthorchiasis induced the severe NAFLD in hamsters fed high-fat/high-fructose diets.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0442
2019-09-03
2020-09-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/101/5/tpmd190442.html?itemId=/content/journals/10.4269/ajtmh.19-0442&mimeType=html&fmt=ahah

References

  1. Sithithaworn P, Andrews RH, Nguyen VD, Wongsaroj T, Sinuon M, Odermatt P, Nawa Y, Liang S, Brindley PJ, Sripa B, 2012. The current status of opisthorchiasis and clonorchiasis in the Mekong basin. Parasitol Int 61: 1016.
    [Google Scholar]
  2. Jittimanee J, Sermswan RW, Puapairoj A, Maleewong W, Wongratanacheewin S, 2007. Cytokine expression in hamsters experimentally infected with Opisthorchis viverrini. Parasite Immunol 29: 159167.
    [Google Scholar]
  3. Prakobwong S, Pinlaor S, Yongvanit P, Sithithaworn P, Pairojkul C, Hiraku Y, 2009. Time profiles of the expression of metalloproteinases, tissue inhibitors of metalloproteases, cytokines and collagens in hamsters infected with Opisthorchis viverrini with special reference to peribiliary fibrosis and liver injury. Int J Parasitol 39: 825835.
    [Google Scholar]
  4. Yongvanit P, Pinlaor S, Bartsch H, 2012. Oxidative and nitrative DNA damage: key events in opisthorchiasis-induced carcinogenesis. Parasitol Int 61: 130135.
    [Google Scholar]
  5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 100: 1441.
    [Google Scholar]
  6. Laothong U, Pinlaor P, Boonsiri P, Hiraku Y, Khoontawad J, Hongsrichan N, Charoensuk L, Pinlaor S, 2013. α-Tocopherol and lipid profiles in plasma and the expression of alpha-tocopherol-related molecules in the liver of Opisthorchis viverrini-infected hamsters. Parasitol Int 62: 127133.
    [Google Scholar]
  7. Adam R, Hinz E, Sithithaworn P, Pipitgool V, Storch V, 1993. Ultrastructural hepatic alterations in hamsters and jirds after experimental infection with the liver fluke Opisthorchis viverrini. Parasitol Res 79: 357364.
    [Google Scholar]
  8. Laothong U, Pinlaor P, Boonsiri P, Pairojkul C, Priprem A, Johns NP, Charoensuk L, Intuyod K, Pinlaor S, 2013. Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters. J Pineal Res 55: 257266.
    [Google Scholar]
  9. Chaidee A et al., 2018. Co-occurrence of opisthorchiasis and diabetes exacerbates morbidity of the hepatobiliary tract disease. Plos Negl Trop Dis 12: e0006611.
    [Google Scholar]
  10. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association, American Association for the Study of Liver Diseases, American College of Gastroenterologyh, 2012. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 142: 15921609.
    [Google Scholar]
  11. Rinella ME, 2015. Nonalcoholic fatty liver disease: a systematic review. JAMA 313: 22632273.
    [Google Scholar]
  12. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA, 2011. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124131.
    [Google Scholar]
  13. Birkenfeld AL, Shulman GI, 2014. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 59: 713723.
    [Google Scholar]
  14. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M, 2016. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64: 7384.
    [Google Scholar]
  15. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E, 2018. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 15: 1120.
    [Google Scholar]
  16. Tacke F, Yoneyama H, 2013. From NAFLD to NASH to fibrosis to HCC: role of dendritic cell populations in the liver. Hepatology 58: 494496.
    [Google Scholar]
  17. Chen Y, Yousaf MN, Mehal WZ, 2018. Role of sterile inflammation in fatty liver diseases. Liver Res 2: 2129.
    [Google Scholar]
  18. Ganz M, Bukong TN, Csak T, Saha B, Park JK, Ambade A, Kodys K, Szabo G, 2015. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. J Transl Med 13: 193.
    [Google Scholar]
  19. Angulo P et al., 2015. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology 149: 389397e10.
    [Google Scholar]
  20. Kanwal F et al., 2018. Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Gastroenterology 155: 18281837e2.
    [Google Scholar]
  21. Wongjarupong N, Assavapongpaiboon B, Susantitaphong P, Cheungpasitporn W, Treeprasertsuk S, Rerknimitr R, Chaiteerakij R, 2017. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol 17: 149.
    [Google Scholar]
  22. Kinoshita M, Kubo S, Tanaka S, Takemura S, Nishioka T, Hamano G, Ito T, Tanaka S, Ohsawa M, Shibata T, 2016. The association between non-alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: a hospital based case-control study. J Surg Oncol 113: 779783.
    [Google Scholar]
  23. Aekplakorn W, Satheannoppakao W, Putwatana P, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, Chariyalertsak S, 2015. Dietary pattern and metabolic syndrome in Thai adults. J Nutr Metab 2015: 468759.
    [Google Scholar]
  24. Thinkhamrop K, Khuntikeo N, Phonjitt P, Chamadol N, Thinkhamrop B, Moore MA, Promthet S, 2015. Association between diabetes mellitus and fatty liver based on ultrasonography screening in the world’s highest cholangiocarcinoma incidence region, northeast Thailand. Asian Pac J Cancer Prev 16: 39313936.
    [Google Scholar]
  25. Sripa B, Bethony JM, Sithithaworn P, Kaewkes S, Mairiang E, Loukas A, Mulvenna J, Laha T, Hotez PJ, Brindley PJ, 2011. Opisthorchiasis and opisthorchis-associated cholangiocarcinoma in Thailand and Laos. Acta Trop 120 (Suppl 1): S158S168.
    [Google Scholar]
  26. Mairiang E, Laha T, Bethony JM, Thinkhamrop B, Kaewkes S, Sithithaworn P, Tesana S, Loukas A, Brindley PJ, Sripa B, 2012. Ultrasonography assessment of hepatobiliary abnormalities in 3359 subjects with Opisthorchis viverrini infection in endemic areas of Thailand. Parasitol Int 61: 208211.
    [Google Scholar]
  27. Charoensuk L, Pinlaor P, Laothong U, Yongvanit P, Pairojkul C, Nawa Y, Pinlaor S, 2014. Bile canalicular changes and defective bile secretion in Opisthorchis viverrini-infected hamsters. Folia Parasitol (Praha) 61: 512522.
    [Google Scholar]
  28. Hongsrichan N, Intuyod K, Pinlaor P, Khoontawad J, Yongvanit P, Wongkham C, Roytrakul S, Pinlaor S, 2014. Cytokine/chemokine secretion and proteomic identification of upregulated annexin A1 from peripheral blood mononuclear cells cocultured with the liver fluke Opisthorchis viverrini. Infect Immun 82: 21352147.
    [Google Scholar]
  29. Lvova MN, Tangkawattana S, Balthaisong S, Katokhin AV, Mordvinov VA, Sripa B, 2012. Comparative histopathology of Opisthorchis felineus and Opisthorchis viverrini in a hamster model: an implication of high pathogenicity of the European liver fluke. Parasitol Int 61: 167172.
    [Google Scholar]
  30. Sithithaworn P, Pipitgool V, Srisawangwong T, Elkins DB, Haswell-Elkins MR, 1997. Seasonal variation of Opisthorchis viverrini infection in cyprinoid fish in north-east Thailand: implications for parasite control and food safety. Bull World Health Organ 75: 125131.
    [Google Scholar]
  31. Morris JL, Bridson TL, Alim MA, Rush CM, Rudd DM, Govan BL, Ketheesan N, 2016. Development of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes. Biol Open 5: 11491162.
    [Google Scholar]
  32. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR, 1999. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94: 24672474.
    [Google Scholar]
  33. Goodman ZD, 2007. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47: 598607.
    [Google Scholar]
  34. Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K, 2012. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56: 17511759.
    [Google Scholar]
  35. Junqueira LC, Cossermelli W, Brentani R, 1978. Differential staining of collagens type I, II and III by sirius red and polarization microscopy. Arch Histol Jpn 41: 267274.
    [Google Scholar]
  36. Lowell BB, Shulman GI, 2005. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384387.
    [Google Scholar]
  37. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Gorgun C, Glimcher LH, Hotamisligil GS, 2004. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457461.
    [Google Scholar]
  38. Yu J, Shen J, Sun TT, Zhang X, Wong N, 2013. Obesity, insulin resistance, NASH and hepatocellular carcinoma. Semin Cancer Biol 23: 483491.
    [Google Scholar]
  39. Patel A, Harrison SA, 2012. Hepatitis C virus infection and nonalcoholic steatohepatitis. Gastroenterol Hepatol (N Y) 8: 305312.
    [Google Scholar]
  40. Onofrio LI, Arocena AR, Paroli AF, Cabalen ME, Andrada MC, Cano RC, Gea S, 2015. Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders. PLoS Negl Trop Dis 9: e0003464.
    [Google Scholar]
  41. Buzzetti E, Pinzani M, Tsochatzis EA, 2016. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism 65: 10381048.
    [Google Scholar]
  42. Changbumrung S, Ratarasarn S, Hongtong K, Migasena P, Vutikes S, Migasena S, 1988. Lipid composition of serum lipoprotein in opisthorchiasis. Ann Trop Med Parasitol 82: 263269.
    [Google Scholar]
  43. Stanley RG, Jackson CL, Griffiths K, Doenhoff MJ, 2009. Effects of Schistosoma mansoni worms and eggs on circulating cholesterol and liver lipids in mice. Atherosclerosis 207: 131138.
    [Google Scholar]
  44. Mukerjee S, Chander R, Tekwani BL, Gupta S, Katiyar JC, Shukla OP, Kapoor NK, 1990. Molecular basis of hyperlipidemia in golden hamsters during experimental infection with Ancylostoma ceylanicum (Nematoda:Strongylidae). Int J Parasitol 20: 217223.
    [Google Scholar]
  45. Kozat S, Denizhan V, 2010. Glucose, lipid, and lipoprotein levels in sheep naturally infected with Fasciola hepatica. J Parasitol 96: 657659.
    [Google Scholar]
  46. Farrell GC, Larter CZ, 2006. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (Suppl 1): S99S112.
    [Google Scholar]
  47. Abdelmalek MF, Suzuki A, Guy C, Unalp-Arida A, Colvin R, Johnson RJ, Diehl AM, Nonalcoholic Steatohepatitis Clinical Research N, 2010. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51: 19611971.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0442
Loading
/content/journals/10.4269/ajtmh.19-0442
Loading

Data & Media loading...

Supplemental table appears

  • Received : 12 Jun 2019
  • Accepted : 29 Jul 2019
  • Published online : 03 Sep 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error